Eric Karas

Chief Commercial Officer

Chief Commercial Officer at ARS Pharmaceuticals, Inc., filing insider transactions between 2025-06-18 and 2026-06-12.

Total Purchases

—

0 transactions

Total Sales

$745K

3 transactions

Companies Traded

3 total filings

Active Since

2025-06-18

Last: 2026-06-12

Companies

ARS Pharmaceuticals, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-12	SPRY	Sale	25.0K	$10.00	$250K	12.2K	SEC ↗
2025-07-01	SPRY	Sale	15.0K	$16.99	$255K	10.3K	SEC ↗
2025-06-18	SPRY	Sale	15.0K	$16.00	$240K	7,696